Table 1.
Differences in baseline characteristics between participants that completed the study and those lost to follow-up (*p < 0.05).
| Overall (n 1471) |
Kin-Réseau (n 506) |
MoPoTsyo (n 484) |
FildCare (n 481) |
|||||
|---|---|---|---|---|---|---|---|---|
| n in FU (781) | n LTFU (690) | n in FU (315) | n LTFU (191) | n in FU (382) | n LTFU (102) | n in FU (84) | n LTFU (397) | |
| Sex (male),% | 29 | 37 | 33 | 33 | 33 | 28 | 21 | 41 |
| Age (mean ± sd) | 58 ± 10 | 60 ± 10 | 59 ± 10 | 63 ± 11 | 55 ± 9 | 60 ± 12 | 59 ± 11 | 63 ± 9 |
| Education primary only or less,% | 50* | 26 | 48 | 51 | 58 | 58 | 22* | 7 |
| Time since diagnosis, med (IQR) | 4 (2–8) | 6 (3–12) | 6 (3–10) | 7 (3–7) | 4 (2–7) | 4 (2–7) | 4 (2–10) | 7 (3–13) |
| Travel distance from educator (hour) | 0.25 | 0.33 | 0.42 | 0.5 | 0.25 | 0.29 | 0.14 | 0.25 |
| HbA1C at start (%, mean ± sd) | 8.2 ± 2.1 | 8.4 ± 2.3 | 8.8 ± 2.3 | 9.1 ± 2.4 | 7.5 ± 1.7 | 7.7 ± 2.0 | 8.6 ± 2.7 | 8.2 ± 2.3 |
| % of people with a HbA1C < 7.0% at start | 35.1% | 34.5% | 23.2% | 22.0% | 44.5% | 39.6% | 38.1% | 39.0% |
| Treatment with insulin,% | 24% | 22% | 49% | 59% | 8% | 11% | 9% | 6% |